Work

Exploratory biomarker results from early investigation of PEGPH20 in combination with gemcitabine (Gem) in patients with pancreatic cancer (PDA).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.300

Authors: Sunil R. Hingorani, William Proctor Harris, Joseph Thaddeus Beck, Boris A. Berdov, Stephanie Ann Wagner, Eduard M. Pshevlotsky, Sergei Tjulandin, Oleg Gladkov, Randall F. Holcombe, Ping Jiang, Daniel C. Maneval, Ronald I Korn, Harold Michael Shepard, Craig E. Devoe

Institutions: Fred Hutch Cancer Center, University of Washington, Highlands Oncology Group, Medical Radiological Research Center, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russian Cancer Research Center NN Blokhin, Chelyabinsk Regional Clinical Oncology Center, Mount Sinai Hospital, Halozyme Therapeutics (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2104157289

Cites:

Cited by: 4

Related to: 10